Literature DB >> 1895146

Uncompacted inner myelin lamellae in inherited tendency to pressure palsy.

H Yoshikawa1, P J Dyck.   

Abstract

Nerves in patients with inherited tendency to pressure palsy (ITPP) are susceptible to degrees of traction or compression which in nonaffected persons do not induce neuropathic symptoms or deficits, conduction block of fibers, or electromyographic changes characteristic of the disorder. Two observations suggest a widespread asymptomatic abnormality of nerves: 1) low conduction velocity of clinically unaffected nerves, and 2) focal thickenings (tomacula) on teased myelinated fibers of clinically unaffected sural nerves. Sural nerves from five patients and five healthy subjects were assessed for morphologic abnormality in ITPP that might account for the susceptibility of nerves to compression. Teased nerve fibers showed a higher frequency of segmental demyelination or remyelination, or both (p less than 0.003). The mean frequency of fibers showing focal myelin thickenings was 57 +/- 10% in ITPP and 0% in controls. In electron micrographs, regions of uncompacted myelin lamellae, usually affecting the innermost lamellae and extending for a variable distance averaging 9 +/- 4 microns were seen in 11 +/- 4% of fibers in ITPP. None were found in the control nerves. The finding of uncompacted myelin lamellae may suggest an abnormality of myelin composition or of interaction of Schwann cells and axons accounting for the increased susceptibility to pressure palsy, tomaculous formation, or demyelination. From electron microscopic evaluation of serial skip sections we infer that myelin of tomaculae is in continuity with internodal myelin and is reduplicated (full-thickness or cleaved layers are longitudinally or circumferentially folded-back on themselves).

Entities:  

Mesh:

Year:  1991        PMID: 1895146     DOI: 10.1097/00005072-199109000-00009

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  8 in total

Review 1.  Inherited focal, episodic neuropathies: hereditary neuropathy with liability to pressure palsies and hereditary neuralgic amyotrophy.

Authors:  Phillip F Chance
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 2.  Animal models for inherited peripheral neuropathies.

Authors:  R Martini
Journal:  J Anat       Date:  1997-10       Impact factor: 2.610

3.  PMP22 expression in dermal nerve myelin from patients with CMT1A.

Authors:  Istvan Katona; Xingyao Wu; Shawna M E Feely; Stephanie Sottile; Carly E Siskind; Lindsey J Miller; Michael E Shy; Jun Li
Journal:  Brain       Date:  2009-05-15       Impact factor: 13.501

4.  Conduction block in PMP22 deficiency.

Authors:  Yunhong Bai; Xuebao Zhang; Istvan Katona; Mario Andre Saporta; Michael E Shy; Heather A O'Malley; Lori L Isom; Ueli Suter; Jun Li
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

Review 5.  Molecular anatomy and genetics of myelin proteins in the peripheral nervous system.

Authors:  G J Snipes; U Suter
Journal:  J Anat       Date:  1995-06       Impact factor: 2.610

6.  Dominantly inherited motor and sensory neuropathy with excessive myelin folding complex.

Authors:  F Umehara; S Takenaga; M Nakagawa; K Takahashi; S Izumo; K Matsumuro; S Sakota; T Nishimura; H Yoshikawa; M Osame
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients.

Authors:  C Vital; R Gherardi; A Vital; N Kopp; J F Pellissier; M Soubrier; P Clavelou; R Bellance; M B Delisle; M M Ruchoux
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 8.  Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells.

Authors:  Hwan Tae Park; Young Hee Kim; Kyung Eun Lee; Jong Kuk Kim
Journal:  Cell Mol Life Sci       Date:  2019-12-28       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.